Trademark: 85960339
Status Date
Friday, March 31, 2023
Registration Number
5043491
Registration Date
Tuesday, September 20, 2016
Filing Date
Friday, June 14, 2013
Published for Opposition
Tuesday, November 25, 2014
Cancellation Date
Friday, March 31, 2023
5 Pharmaceutical preparations for the treatment of psoriasis, and pharmaceutical substances, namely, for the prediction of response to anti-Tumor Necrosis Factor, also known as TNF, therapies and sanitary preparations for the prediction of response to anti-Tumor Necrosis Factor therapies; diagnostic preparations and substances for medical use; diagnostic kits consisting primarily of multiplex polymerase chain reaction reagents and biochip array reagents; clinical diagnostic preparations for medical use; clinical diagnostic reagents for medical in vitro and/or vivo use; diagnostic scanning agents for in-vivo use used for the prediction of response to anti-Tumor Necrosis Factor therapies; diagnostic testing materials, namely, diagnostic preparations, reagents and contrast media for medical use; clinical medical reagents; reagents for use in diagnostic tests for medical purposes; reagents for use with analyzers for medical purposes; parts and fittings for all the aforesaid goods, namely, multiplex polymerase chain reaction reagents and biochip array reagents; chemical reagents for medical purposes; enzymes for medical purposes
1 Chemicals used in industry, science, photography, agriculture, horticulture and forestry; chemical reagents other than for medical purpose; enzymes for scientific and research purposes and proteins for industrial use; diagnostic preparations for scientific purposes; clinical diagnostic preparations or reagents other than for medical use; diagnostic preparations, namely, diagnostic scanning agents; diagnostic testing materials, namely, diagnostic preparations, reagents and contrast media other than for medical use; chemical reagents for use in diagnostic tests, other than for medical use; clinical diagnostic reagents for laboratory in vitro and/or vivo use
44 Medical services; providing health advice and information services; medical care services; health clinic services; healthcare services, namely, geriatric health care, physical therapy; medical health assessment services, namely, providing prediction of response to anti-Tumor Necrosis Factor therapies; diagnostic health screening services in the field of psoriasis; medical testing for prediction of response to therapy; medical diagnostic testing services; genetic testing for medical for medical purposes; medical clinics; advice, information and consultancy services for all of the aforesaid services
42 Scientific and technological services, namely, research and design in the field of psoriasis; medical research services; clinical research services, namely, conducting clinical trials for others; biological research; conducting clinical trials for others, namely, analysis, management and reporting of clinical data; consulting services in the field of quality assessment services for clinical laboratories; chemical research; chemical laboratory services; chemical analysis; scientific and medical laboratory services for analytical testing; medical laboratory services; biochemistry research and consultant advisory services; conducting clinical trials for others; providing computer aided diagnostic testing services for predicting response to anti-Tumor Necrosis Factor therapies for others in the field of science and research related thereto; scientific and technological services, namely, development of test equipment for medical apparatus for others; advice, information and consultancy services relating to all the aforesaid services
Mar 31, 2023
Cancelled Sec. 8 (6-Yr)
Sep 20, 2021
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Sep 20, 2016
Registered-Principal Register
Aug 15, 2016
1(B) Basis Deleted; Proceed To Registration
Jul 11, 2016
Notice Of Allowance Cancelled
Jul 11, 2016
Teas Delete 1(B) Basis Received
Dec 29, 2015
Notice Of Approval Of Extension Request E-Mailed
Dec 28, 2015
Sou Extension 2 Granted
Dec 17, 2015
Sou Extension 2 Filed
Dec 17, 2015
Teas Extension Received
Dec 17, 2015
Teas Change Of Correspondence Received
Aug 6, 2015
Notice Of Approval Of Extension Request E-Mailed
Aug 5, 2015
Sou Extension 1 Granted
Jul 20, 2015
Sou Extension 1 Filed
Aug 5, 2015
Case Assigned To Intent To Use Paralegal
Jul 20, 2015
Teas Extension Received
Jan 20, 2015
Noa E-Mailed - Sou Required From Applicant
Nov 25, 2014
Official Gazette Publication Confirmation E-Mailed
Nov 25, 2014
Published For Opposition
Nov 5, 2014
Notification Of Notice Of Publication E-Mailed
Oct 22, 2014
Law Office Publication Review Completed
Oct 22, 2014
Approved For Pub - Principal Register
Oct 6, 2014
Data Modification Completed
Oct 3, 2014
Teas/Email Correspondence Entered
Oct 3, 2014
Correspondence Received In Law Office
Oct 3, 2014
Teas Response To Suspension Inquiry Received
May 19, 2014
Notification Of Letter Of Suspension E-Mailed
May 19, 2014
Letter Of Suspension E-Mailed
May 19, 2014
Suspension Letter Written
May 6, 2014
Examiner's Amendment Entered
May 6, 2014
Notification Of Examiners Amendment E-Mailed
May 6, 2014
Examiners Amendment E-Mailed
May 6, 2014
Examiners Amendment -Written
May 1, 2014
Notification Of Letter Of Suspension E-Mailed
May 1, 2014
Letter Of Suspension E-Mailed
May 1, 2014
Suspension Letter Written
Apr 8, 2014
Teas/Email Correspondence Entered
Apr 8, 2014
Correspondence Received In Law Office
Apr 4, 2014
Assigned To Lie
Mar 25, 2014
Teas Response To Office Action Received
Sep 27, 2013
Notification Of Non-Final Action E-Mailed
Sep 27, 2013
Non-Final Action E-Mailed
Sep 27, 2013
Non-Final Action Written
Sep 24, 2013
Assigned To Examiner
Jun 25, 2013
New Application Office Supplied Data Entered
Jun 18, 2013
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
